FDA approves Abbott's LCx gonorrhoea test:
This article was originally published in Clinica
Executive Summary
Abbott Laboratories has received US FDA approval for its gonorrhoea test for use with the company's LCx Probe System. The new test, based on Abbott's ligase chain reaction amplification technology, will allow laboratories to detect gonorrhoea in urine samples, as well as with swabs. It can be used in tandem with the company's LCx chlamydia test. Current tests for gonorrhoea, which is often asymptomatic and underdiagnosed, are "invasive, uncomfortable, time-consuming and labour-intensive", says Abbott. As a result they are not commonly used unless patients believe they have been infected.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.